The article introduces NucleoBench and AdaBeam, new tools for advancing nucleic acid design in biotechnology. These AI-powered platforms aim to improve the precision and efficiency of genetic engineering and therapeutic applications.
OpenAI and Retro Bio collaborated using a specialized AI model called GPT-4b micro to engineer more effective proteins for stem cell therapy and longevity research. This represents a significant application of AI technology in advancing life sciences and medical research capabilities.
NVIDIA has made Evo 2, the largest publicly available AI foundation model for genomic data, accessible through its BioNeMo platform. The model was developed in collaboration with Arc Institute and can understand genetic code across all domains of life, built on NVIDIA's DGX Cloud platform.
The article title indicates a partnership between Ryght and Hugging Face aimed at empowering healthcare and life sciences sectors, but the article body appears to be empty or unavailable for analysis.
